Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages

International Journal of Pharmaceutics

Volumn 269, Issue 1, 2004, Pages 37-49

  Vyas, S P ^a   Kannan, M E ^a   Jain, Sanyog ^a   Mishra, V ^a   Singh, Paramjit ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Aerosolized liposomes; Alveolar macrophages; MBSA; O SAP; Rifampicin; Tuberculosis

Indexed keywords

AMYLOPECTIN; BOVINE SERUM ALBUMIN; CHLOROFLUOROCARBON; CHOLESTEROL DERIVATIVE; DICETYL PHOSPHATE; LIPOSOME; PHOSPHATIDYLCHOLINE; RIFAMPICIN;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 0347418154     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.08.017     Document Type: Article

References (31)

1. Adamson, A.W., 1967. Physical Chemistry of Surface, 2nd ed. Interscience, New York.
2. Bermudez L.E. Use of liposome preparation to treat mycobacterial infections. Immunobiology. 191:1994;578-583.
3. Chaudhuri G., Mukhopadhyay A., Basu S. Selective delivery of drugs to macrophages through a highly specific receptor: an efficient chemotherapeutic approach against leishmaniasis. Biochem. Pharmacol. 38:1989;2995-3002.
4. Deol P., Khullar G.K. Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochim. Biophys. Acta. 1334:1997;161-172.
5. Farr S.J., Kellaway I.W., Parry Jones D.R., Woolfrey S.G. 99m-Technetium as a marker of liposome disposition and clearance in the human lung. Int. J. Pharm. 26:1985;303-316.
6. Farr S.J., Kellaway I.W., Carman-Meaking B. Assessing the potential of aerosol generated liposomes from pressurized pack formulations. J. Control. Release. 5:1987;119-127.
7. Fidler I.J., Raz A., Fogler W.E., Kirsh R., Bugleski P., Poste G. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res. 40:1980;4460-4466.
8. Gupta P.K., Huang C.T. Albumin microspheres I - physicochemical characteristics. J. Microencapsul. 6:1989;427-462.
9. Hermanson, G.T., 1996. Bioconjugate Techniques. Academic Press Inc., San Diego, California, pp. 528-569.
10. Jain C.P., Vyas S.P. Preparation and characterization of niosomes containing rifampicin for lung targeting. J. Microencapsul. 12:1995;401-407.
11. Jamaluddin A.B., Sarwar G., Rahim M.A., Rahman M.K. High-performance liquid chromatographic assay of rifampicin in human serum. J. Chromatogr. 525:1990;495-497.
12. Kirk W.F. In vitro method of comparing clouds produced from inhalation aerosols for efficiency in penetration of airways. J. Pharm. Sci. 61:1972;262-264.
13. Kirsh, R., Bugleski, P.J., Poste, G., 1987. Drug delivery to macrophages for the therapy of cancer and infectious diseases. In: Juliano, R.L. (Ed.), Biological Approaches to the Controlled Delivery of Drugs. The New York Academy of Sciences, New York, pp. 141-154.
14. Mandell, G.L., Sande, H.A., 1985. Antimicrobial agents. In: Gilman, G.A., Goodman, A. (Eds.), The Pharmacological Basis of Therapeutics, 7th ed. Macmillan, New York, pp. 1202-1205.
15. Mukhopadhyay A., Chaudhuri G., Arora S., Sehgal S., Basu S. Receptor mediated drug delivery to macrophages in chemotherapy of leishmaniasis. Science. 244:1989;705-707.
16. Myers M.A., Thomas D.A., Straub L., Soucy D.W., Niven R.W., Kaltenbach M., Hood C.I., Schreier H., Gonzalez-Rothi R.J. Pulmonary effects of chronic exposure to liposome aerosols in mice. Exp. Lung Res. 19:1993;1-19.
17. Nakhare S., Vyas S.P. Prolonged release multiple emulsion based system bearing rifampicin: in vitro characterization. Drug Dev. Ind. Pharm. 21:1995a;869-875.
18. Nakhare S., Vyas S.P. Prolonged release of rifampicin from multiple w/o/ w emulsion systems. J. Microencapsul. 12:1995b;409-415.
19. Nakhare S., Vyas S.P. Multiple emulsion based systems for prolonged delivery of rifampicin: in vitro and in vivo characterization. Die Pharmazie. 52:1997;224-226.
20. New, R.R.C., 1990. Introduction and preparation of liposomes. In: New, R.R.C. (Ed.), Liposomes: A Practical Approach. Oxford University Press, Oxford, pp. 1-104.
21. Ostro, M.J., 1987. Liposomes: From Biophysics to Therapeutics. Marcel Dekker Inc., New York.
22. Pandey S., Vyas S.P., Dixit V.K. Localized rifampicin albumin microspheres. J. Microencapsul. 8:1991;87-93.
23. Rigotti A., Acton S.L., Krieger M. The class B scavenger receptor SR-B1 and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270:1995;16221-16224.
24. Rothi R.J.G., Harris J.O. Effects of low cigarette smoke inhalation on rat lung macrophages. J. Toxicol. Environ. Health. 17:1986;221-227.
25. Scherphof, G.L., 1991. In vivo behavior of liposomes. In: Juliano, R.L. (Ed.), Targeted Drug Delivery. Springer Verlag, Berlin, New York, pp. 285-300.
26. Sciarra, J.J., Cutie, A.J., 1987. In: Lachman, L., Liberman, A., Kanig J.L. (Eds.), The Theory and Practice of Industrial Pharmacy, 3rd ed. Lea and Febiger, Philadelphia, 589-618.
27. Sunamoto, J., Gato, M., Iida, T., Hara, K., Saito, A., Tomonega, A., 1985. Polymer coated liposomes for drug delivery to target specific organs. In: Gregoriadis, G., Senior, J., Trouet, A. (Eds.), Receptor Mediated Targeting of Drugs. Plenum Press, New York, pp. 359-371.
28. Sunamoto J., Sato T., Hirota M., Fukushima K., Hiratani K., Hara K. A newly developed immunoliposome - an egg phosphatidylcholine liposome coated with pullulan bearing both a cholesterol moiety and an IgMs fragment. Biochim. Biophys. Acta. 898:1987;323-330.
29. Takada M., Yuzuriha T., Katayama K., Iwamoto K., Sunamoto J. Increased lung uptake of liposome coated with polysaccharides. Biochim. Biophys. Acta. 802:1984;237-244.
30. Thomas D.A., Myers M.A., Wichert B., Schreier H., Gonzalez-Rothi R.J. Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers. Chest. 99:1991;1268-1270.
31. Vyas S.P., Sakthivel T. Pressurized pack-based liposomes for pulmonary targeting of isosprenaline - development and characterization. J. Microencapsul. 11:1994;373-380.